The United Kingdom Bronchiectasis Registry (BRONCH-UK) is a national research database and biobank of adults with bronchiectasis.
The aim is to facilitate clinical trials and academic research studies in order to improve our understanding of what causes bronchiectasis and to find better, more effective treatment for people with this condition.
The project is an initiative of the Bronchiectasis Research Academic network (BRAN) and funded by the Medical Research Council.
BRAN is a national network of doctors, allied healthcare professionals and scientists across the UK with the aims to promote good clinical care and facilitate research and communication among clinicians and researchers in Bronchiectasis.
Members of BRAN have worked on several single centre and national multi-centre clinical studies and developed the Bronchiectasis severity index (BSI)
It is our great pleasure to invite you to participate, and more importantly to actively contribute to the 3rd European Bronchiectasis Workshop (EBROW 2023).
Previous editions of the World …Read More
Our collaborators Dundee who oversee the EMBARC network have two bronchiectasis trials which will start very soon and are looking for new sites to join the studies. A brief description of the VITAL- …Read More
The 5th World Bronchiectasis & NTM Conference 2022 was held in Prague this year (30 June – 2nd July). The event was well attended with wide ranging expertise and considered a huge success. …Read More
BronchUK has now closed to recruitment with 1,630 patients consented to take part in the registry from across 15 UK sites.
Study teams will now focus on completion of patient follow-ups over a five …Read More
The 5th WBNC will be held in Prague 30th June – 2nd July 2022 with plans of a hybrid conference experience so those who cannot travel will not miss out!
The late breaking abstract window for …Read More
EMBARC clinicians have been working with the ELF patient advisory group to develop the 2nd Bronchiectasis Patient Conference programme. Similar to last year, the conference will be held online and …Read More
BronchUK has been awarded a Certificate of Achievement from the Clinical Research Network for succesfully recruiting to time and target.
BronchUK currently has over 1,500 patients recruited …Read More
Please find below some important dates of interest for bronchiectasis patients, researchers and healthcare professionals.
ERS Congress submission deadline – 22nd February 2022
The deadline …Read More
We have updated our publications page with recent papers from our BronchUK collaborators. Abstracts and links to full texts are available - why not take a look: https://www.bronch.ac.uk/latest- …Read More
The BronchUK: protocol for an observational cohort study and biobank in bronchiectasis, was published by ERJ Open Research - European Respiratory Society in 2020.
Thank you to all contributors …Read More
The European respiratory society guidelines on bronchiectasis were released in September 2017 . We are delighted that many BronchUk members were key participants in this multnational guidelines …Read More
BronchUK team describe new treatment for severe pseudomonas infection in top ranking Respiratory Journal, American Resp. Critical Care Medicine. Press releases from Birmingham and Newcastle …Read More
BronchUK member publishes new website for patients at www.bronchiectasis.me. The Newcastle team have co-developed with patients a website for patients. It has now gone live.Read More
BronchUK members are told they have been successfully entered into the European Rare Diseases Network. Members Haworth (Cambridge), Loebinger (Brompton, London) and De Soyza (Newcastle) have been …Read More
This important paper may help define future cross infection control measures.Read More
Prof Ian Henderson has been awarded a grant to extend work from the J Exp Med Paper 2014 Wells et al assessing “blocking antibodies” . Co-applicants Chalmers (Dundee) and De Soyza ( …Read More
A greater understanding into Bronchiectasis is at the forefront of the work carried out by the Freeman Hospital's Respiratory Research Team in the Bronch UK Study.
This month Freeman's team …Read More
BronchUK are delighted to announce the consortium's very active involvement with the ground breaking 100,000 genomes project.
A number of consortium members helped in the bidding process for …Read More
Read the article hereRead More
Bronch-UK researchers are involved in a number of poster and spoken presentations at the ERS meeting in Amsterdam in September.
Atorvastatin as an anti-inflammatory in bronchiectasis. …Read More
Bronch-UK researchers are involved in a number of poster and spoken presentations at the BTS meeting in London in December.
Vidya Navaratnam – Admission trends and outcomes of …Read More
Bronch-UK researchers are contributing to a €50 million, Europe-wide, project to develop new drugs that could improve the lives of patients with cystic fibrosis and bronchiectasis.
The …Read More
The MRC funded UK Bronch collaboration will formally launch on the 1st November 2014 with participation from 9 sites across the UK.Read More
Tony De Soyza gave a talk at the recent meeting on Asthma, COPD and Concomitant Chronic Diseases Meeting held in Firenze, Italy.
Download BCOS- it matters March 2015 5th De Soyza PDFRead More
Tony De Soyza presented a talk on Bronchiectasis Pipelines and Networks - see below
Download Bronchiectasis pipelines and networks Dec BTS 2014 De Soyza Churchill
A picture of the packed …Read More
The UK Bronchiectasis network has participated in a multicentre study to derive and validate the first clinical prediction tool for bronchiectasis. The article, published in the American Journal of …Read More
Dr Anthony De Soyza and colleagues have published the results of a network consultation to define the key research priorities in bronchiectasis. Read the results at http://thorax.bmj.com/content/68/7/ …Read More